Skip to main content

Table 6 Characteristics of patients with failure

From: Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation

Age at Diagnosis

Menopause Status

ASTRO Category

Size

Histology

Grade

Biomarker Pattern

Node Biopsy

Adjuvant Treatment

Radiation Modality

Initial Failure

Failure (months)

Salvage Treatment

Current Status

61.7

Post

cautionary

1.00

DCIS

II

+/-/?

No

R + E

APBI

Local - E

20.3

MRM + C + E

NED

62.1

Post

acceptable

0.30

IDC

I

+/+/-

Yes

R + E

APBI

Local - T

45.3

MRM + C

NED

66.8

Post

acceptable

1.00

IDC

II

+/+/-

Yes

R + E

APBI

Local - E

59.6

SM

NED

69.3

Post

acceptable

2.00

IDC

II

+/-/-

Yes

R + E

APBI

Local - E

38.2

PM + C + WBI + E

NED

59.5

Post

cautionary

2.00

IDC

II

+/-/-

Yes

R + E + C

APBI

Local - E

47.1

MRM + C + E

NED

68.2

Post

cautionary

0.90

IDC

III

-/-/-

Yes

R

WBI

Local - E

49.5

MRM

NED

57.0

Post

cautionary

1.50

IDC

III

-/-/-

Yes

R + C

WBI

Local - T

5.2

SM

NED

56.5

Post

cautionary

0.90

DCIS

III

+/+/?

No

R

WBI

Local - T

49.3

SM

NED

62.3

Post

acceptable

0.60

IDC

II

+/+/-

Yes

R + E

WBI

Local - E

97.5

MRM + E

NED

45.4

Pre

unsuitable

3.00

IDC

II

+/+/-

Yes

R + E + C

APBI

Regional

55.0

SR + C

Expired

53.6

Post

cautionary

3.00

IDC

II

+/+/-

Yes

R + E

APBI

Regional

17.1

SR + C + R

NED

70.7

Post

cautionary

0.80

IDC

III

-/-/-

Yes

R

APBI

Metastatic

32.4

C + H

Expired

68.6

Post

cautionary

1.00

IDC

III

+/+/-

Yes

R

WBI

Metastatic

13.2

-

Expired

71.1

Post

cautionary

2.10

IDC

III

-/-/+

Yes

R + C

APBI

Metastatic

45.4

C + R

Under Treatment

56.5

Post

cautionary

2.90

IDC

III

+/+/+

Yes

R + C + E

APBI

Metastatic

60.8

R

Under Treatment

58.1

Post

cautionary

1.50

IDC

II

+/-/-

Yes

R

WBI

Metastatic

46.1

C

Under Treatment

  1. Abbreviations: SM simple mastectomy, MRM modified radical mastectomy, PM partial mastectomy, R radiotherapy, C chemotherapy, E endocrine therapy, H Herceptin, Local-T - true recurrence, Local-E - elsewhere recurrence. Biomarker pattern shows the status for estrogen receptor, progesterone receptor, and HER2/neu using the following symbolic code: (ER)/(PR)/(HER2/neu). Presence of the biomarker is indicated by '+,' absence by '-,' unknown by '?.'